Galapagos NV (NASDAQ:GLPG)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $53.93, but opened at $54.49. Galapagos NV shares last traded at $55.54, with a volume of 51,241 shares trading hands.

A number of equities analysts have recently issued reports on GLPG shares. Zacks Investment Research upgraded shares of Galapagos NV from a “sell” rating to a “hold” rating in a research report on Wednesday, May 4th. Cowen and Company reiterated a “buy” rating on shares of Galapagos NV in a research report on Saturday, April 30th. Morgan Stanley reiterated a “buy” rating and set a $89.00 target price on shares of Galapagos NV in a research report on Monday, May 2nd. Finally, Credit Suisse Group AG reiterated a “hold” rating and set a $48.00 target price on shares of Galapagos NV in a research report on Friday, June 17th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Galapagos NV presently has an average rating of “Buy” and a consensus price target of €65.50 ($72.78).

The firm’s 50-day moving average is $53.66 and its 200 day moving average is $48.82. The firm’s market cap is $2.53 billion.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.